amt-191
·Code: AMT-191
amt-191: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| uniQure N.V. (QURE) | Phase 1/Phase 2 |
Clinical Trials (1)
A Phase 1/2, Single Dose, Dose Ranging Study of Intravenous AAV5-GLA (AMT-191) in Adult Males With Classic Fabry Disease
Frequently asked questions
Who is developing amt-191?
amt-191 is being developed by uniQure N.V..
How many clinical trials involve amt-191?
BioSniper tracks 1 clinical trial involving amt-191.
Get deeper analysis on amt-191
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis